| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |